|Virbac has introduced Inflacam®, a meloxicam-based NSAID indicated for the alleviation of pain in both acute and chronic musculoskeletal disorders in dogs and horses.Inflacam is presented both as an oral suspension and as a chewable tablet for dogs.
The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes – 1 mg and 2.5 mg – and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, comments: “Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice ‘standards’ for everyday use. Inflacam fits this brief well – meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range.”
For more information vets are advised to contact their territory manager or call Virbac on 01359 243 243.
Founded by a veterinary surgeon, Virbac is the largest independent veterinary pharmaceutical company in the world and is dedicated to supporting the veterinary profession through the development of innovative products and services, which support their businesses and help animals lead longer, healthier lives.